Tandem Diabetes Care, Inc. Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount
Tandem Diabetes Care, Inc. (TNDM) reported Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount of -$1.42 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount · last filed 2026-02-19
- Tandem Diabetes Care, Inc. effective income tax rate reconciliation cross border tax effect amount for fiscal 2024 was -$1.42M.
- Tandem Diabetes Care, Inc. effective income tax rate reconciliation cross border tax effect amount for fiscal 2023 was -$307.00K, a 1090.32% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. effective income tax rate reconciliation cross border tax effect amount for fiscal 2022 was $31.00K.
| Period end | Effective Income Tax Rate Reconciliation Cross Border Tax Effect Amount 12 month |
|---|---|
| 2024-12-31 | -$1.42M 10-K · filed 2026-02-19 |
| 2023-12-31 | -$307.00K 10-K · filed 2026-02-19 |
| 2022-12-31 | $31.00K 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |